European CHMP issues Positive Opinion for repeated intermittent use of Esmya 5 mg in the long term management of Uterine Fibroids
4/27/2015
Business related Regulatory Marketing authorization application Women's Healthcare PRODUCT - ESMYA API - ULIPRISTAL ACETATE